[ad_1]
The company, based in Gaithersburg, has received hundreds of millions in federal dollars to boost production of COVID-19 therapies and vaccines, including at the East Baltimore factory near Johns Hopkins Bayview Medical Center. That plant has a history of violations dating back at least a year, including insufficient employee training, a lack of standardization of quality-control measures, and a non-adherence to test procedures and laboratory control mechanisms.
[ad_2]
Source link
Source: Baltimore Sun